MMP9 and neoplasm: TANs promote angiogenesis at the invasive tumor front via a Matrix Metalloproteinase-9 (MMP-9) release [108,111,112], and chemokines such as CXCL1 and CXCL5 facilitate neutrophil infiltration, correlating with a poor prognosis [109].